12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Tuesday's intraday session, several healthcare stocks experienced significant movements. Tenax Therapeutics (TENX) saw a massive increase of 319.0% to $0.65 with an exceptionally high trading volume. Tivic Health Systems (TIVC) rose by 68.89% following their Q3 earnings release. ZyVersa Therapeutics (ZVSA), INVO Bioscience (INVO), MSP Recovery (LIFW), and Tenon Medical (TNON) also saw gains ranging from 18.27% to 32.88%. On the downside, TC BioPharm (TCBP) plummeted by 90.0%, Aclaris Therapeutics (ACRS) dropped by 86.77%, and other stocks like Mainz Biomed (MYNZ), Verve Therapeutics (VERV), TRACON Pharma (TCON), and Alector (ALEC) experienced declines between 16.58% and 45.54%.
November 14, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aclaris Therapeutics stock experienced a sharp decline of 86.77%, with a surge in trading volume.
The significant drop in price, accompanied by a large increase in trading volume, suggests a strong negative market reaction that could affect the stock's short-term performance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 90
NEGATIVE IMPACT
Alector stock fell 16.58%, with trading volume nearing average levels.
The stock's decline, although not as drastic as others, indicates a negative trend that could impact the stock's short-term trajectory.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Mainz Biomed shares declined by 45.54%, potentially due to unfavorable market conditions or company-specific news.
The substantial decrease in stock price could be driven by negative sentiment or disappointing news, which may continue to influence the stock negatively in the short term.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 80
NEGATIVE IMPACT
TC BioPharm stock plummeted by 90.0%, indicating a severe market reaction.
Such a drastic decline in stock price typically reflects extremely negative news or market sentiment, which could have a continued negative impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 95
RELEVANCE 100
NEGATIVE IMPACT
TRACON Pharma stock declined by 24.41%, three days after their Q3 earnings were reported.
The decline in stock price following the Q3 earnings suggests that the market may have had a delayed negative reaction to the earnings report or other factors.
CONFIDENCE 65
IMPORTANCE 65
RELEVANCE 70
NEGATIVE IMPACT
Verve Therapeutics stock decreased by 40.77%, with trading volume exceeding average levels.
The significant stock price drop and high trading volume point to negative investor sentiment, which could persist in the short term.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
INVO Bioscience's stock rose by 22.18% following their Q3 earnings report.
The increase in stock price after the Q3 earnings report suggests that the earnings may have exceeded market expectations, influencing short-term price movement.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
MSP Recovery shares increased by 18.45% with a significant rise in trading volume.
The stock's gain and increased trading volume suggest positive news or market sentiment that could continue to influence the stock in the short term.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 70
POSITIVE IMPACT
Tenax Therapeutics stock soared 319.0% with trading volume massively exceeding the average, indicating strong investor interest.
The extraordinary volume surge and price increase suggest a very positive market reaction, likely due to a significant catalyst or news, which could continue to drive short-term momentum.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Tivic Health Systems stock jumped 68.89% possibly in response to their Q3 earnings release.
The significant stock price increase on the day of the Q3 earnings release suggests the market has responded positively to the financial results or forward-looking statements.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Tenon Medical shares rose by 18.27% on the day their Q3 earnings were released.
The positive stock movement coinciding with the Q3 earnings release indicates a favorable investor reaction to the company's financial performance.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 70
POSITIVE IMPACT
ZyVersa Therapeutics stock increased by 32.88% with a notable rise in trading volume.
The substantial price increase and higher than average trading volume indicate positive investor sentiment, which may impact the stock price in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80